Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03880266 · ClinicalTrials.gov registry record · Phase 2
A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis
A Phase 2 study, sponsored by Journey Medical Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 72
- Enrollment target
NCT03880266 is a Phase 2 study that has completed, run by Journey Medical Corporation. The registered enrollment target is 72 participants.
The verdict
NCT03880266, a Phase 2 study, has completed, sponsored by Journey Medical Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 72 participants
- Enrollment target
Study Summary
The objective of this study is to assess the efficacy and safety of glycopyrronium cloth, 2.4% when used to treat palmar hyperhidrosis.
Interventions
- DRUG Vehicle
- DRUG Glycopyrronium cloth, 2.4%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2019-02-22 |
| Est. Completion | 2019-05-24 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03880266
The ClinicalTrials.gov registry entry for NCT03880266 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Journey Medical Corporation, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT03880266 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03880266 about?
NCT03880266 is a clinical study titled "A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis". The objective of this study is to assess the efficacy and safety of glycopyrronium cloth, 2.4% when used to treat palmar hyperhidrosis.
What is the current status of trial NCT03880266?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 72 participants. The study started on 2019-02-22. Estimated completion is 2019-05-24.
What interventions are being tested in trial NCT03880266?
The interventions under investigation include: Vehicle (DRUG), Glycopyrronium cloth, 2.4% (DRUG).
Who is sponsoring clinical trial NCT03880266?
This trial is sponsored by Journey Medical Corporation, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.